ReviewThe Lancet regional health. Southeast Asia2025
Financial toxicity of hemophilia care in Southeast Asian countries.
Review in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Regional variations and trends in hemophilia prevalence: A global analysis with future projection.PLOS global public health · 2026Article
- The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries - For Whom, by Whom and Where?Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hemophilia is a rare, chronic bleeding disorder with high treatment costs that pose significant economic challenges, particularly in many countries of Southeast Asia (SEA), where disease burden is disproportionately high. In this commentary, we explore the drivers of financial toxicity (FT) in hemophilia care across SEA. We identify key contributors including inadequate health insurance coverage, reliance on unstable humanitarian aid, geographic disparities in care access, and cultural factors that place financial and emotional strain on families. Despite some policy efforts-such as universal health coverage and national cancer control plans-systemic gaps in financing, infrastructure, and provider distribution persist. We propose actionable steps using the social ecological model of health to reduce FT at the individual, interpersonal, community, and policy levels, including expanded insurance coverage, decentralized care, telehealth access, financial navigation services, and public education. Addressing the multifactorial nature of FT is essential to improving quality of life and equity in care for patients with hemophilia in SEA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.